These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1022903)

  • 1. [Viscosity of blood, plasma and serum, in the vessels of the lesser and greater circulation in rheumatic mitral heart defect].
    Solov'ev GM; Gudenko VV
    Kardiologiia; 1976 Jun; 16(6):97-101. PubMed ID: 1022903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Blood rheology and central hemodynamics in rheumatic mitral valve diseases].
    Murashko VV; Dzhanashiia PKh; Shardanov NA; Kaĭdash AN; Khurtsilava SG
    Revmatologiia (Mosk); 1983; (2):26-9. PubMed ID: 6353510
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of the rheological properties of the blood on the intracardiac hemodynamics in patients with acquired mitral valve defects].
    Murashko VV; Dzhanashiia PKh; Chigogidze NA; Petrosian IuS
    Kardiologiia; 1988 May; 28(5):69-72. PubMed ID: 3411864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bile acid levels in the serum and the state of liver blood flow in patients with rheumatic mitral heart disease].
    Diadyk AI; Chernomorets NN; Alifanova RE; Seleznev AV; Ivashchenko IV
    Vrach Delo; 1991 Jun; (6):45-7. PubMed ID: 1891850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of the pre-clinical stage of circulatory insufficiency in mitral valve defect].
    Tsfasman AZ; Kassirskiĭ GI; Goloshchapov VIu; Davitinidze NL
    Kardiologiia; 1976 Jun; 16(6):109-14. PubMed ID: 1022882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characteristics of the acid-base equilibrium of the blood in pregnant women with mitral heart disease of rheumatic origin].
    Nikolaeva ND
    Vopr Okhr Materin Det; 1971 Jan; 16(1):69-72. PubMed ID: 5575093
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the diagnosis of the 3d and 4th stages of circulatory disorders (according to A. N. Bakulev) in patients with rheumatic mitral defects of the heart].
    Radzivil GG
    Kardiologiia; 1967 Sep; 7(9):96-103. PubMed ID: 5607934
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma brain natriuretic peptide levels in patients with rheumatic heart disease.
    Gölbaşý Z; Uçar O; Yüksel AG; Gülel O; Aydoğdu S; Ulusoy V
    Eur J Heart Fail; 2004 Oct; 6(6):757-60. PubMed ID: 15542413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Indices of the functional state of peripheral blood lymphocytes in the early postoperative period in rheumatic heart defects].
    Miansarian IT
    Zh Eksp Klin Med; 1979; 19(3):102-7. PubMed ID: 494879
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma NT-proBNP is a potential marker of disease severity and correlates with symptoms in patients with chronic rheumatic valve disease.
    Davutoglu V; Celik A; Aksoy M; Sezen Y; Soydinc S; Gunay N
    Eur J Heart Fail; 2005 Jun; 7(4):532-6. PubMed ID: 15921791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of hyperbaric oxygenation on the circulatory function in rheumatic mitral valve disease].
    Efuni SN; Rabkin IKh; Rodionov VV; Bukaev IuN; Svirshchevskiĭ EB
    Kardiologiia; 1977 Mar; 17(3):29-36. PubMed ID: 886698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemodynamic changes in the greater and lesser circulations of patients with a mitral heart defect and primary pulmonary hypertension under the influence of differentiated treatment].
    Konopleva LF; Shevchuk SG; Karpenko VV; Fedorishko SS; Kisil' SS
    Vrach Delo; 1991 Oct; (10):50-2. PubMed ID: 1803746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antioxidant systems of erythrocytes in rheumatism].
    Kozlov GS; Noskov SM
    Ter Arkh; 1985; 57(8):121-3. PubMed ID: 4071426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fibrinogen metabolism in congestive circulatory insufficiency].
    Belousov IuB; Sidorskiĭ AL; Abazova FI; Savenkov MP
    Kardiologiia; 1977 Dec; 17(12):94-8. PubMed ID: 599832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Atrial natriuretic peptide in rheumatic mitral valve disease].
    Hryniewiecki T; Rawczyńska-Englert I; Orłowska-Baranowska E; Pszona B
    Pol Arch Med Wewn; 1993 Apr; 89(4):293-7. PubMed ID: 8351229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemostasis and the rheologic properties of the blood in patients with rheumatic mitral stenosis].
    Dziak GV; Vulykh NV
    Vrach Delo; 1989 Jul; (7):82-4. PubMed ID: 2800514
    [No Abstract]   [Full Text] [Related]  

  • 17. [Role of active rheumatic infection in the genesis of thrombosis and hypertension in the blood vessels of the lesser circulation in patients with mitral heart defects].
    Sidarenko LN; Morozova LI; Sviriakin VT; Dyganiĭ AA; Ivchenko VI
    Vopr Revm; 1974; (3):28-31. PubMed ID: 4432436
    [No Abstract]   [Full Text] [Related]  

  • 18. Mitral regurgitation reduces systemic coagulation activity in patients with rheumatic heart disease.
    Cevik C; Otahbachi M; Nugent K; Ozkan M
    J Heart Valve Dis; 2009 May; 18(3):278-83. PubMed ID: 19557983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet survival in patients with rheumatic heart disease.
    Steele PP; Weily HS; Davies H; Genton E
    N Engl J Med; 1974 Mar; 290(10):537-9. PubMed ID: 4811098
    [No Abstract]   [Full Text] [Related]  

  • 20. Normal sinus rhythm in advanced mitral valve disease.
    Kaplan MA; Parker DP; Aronow W; Resnick N
    Arch Intern Med; 1969 Jun; 123(6):660-3. PubMed ID: 5771053
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.